Design, synthesis, and antifungal activity of novel cinnamon-pyrazole carboxamide derivatives

Drug Dev Res. 2018 Sep;79(6):307-312. doi: 10.1002/ddr.21469. Epub 2018 Sep 26.

Abstract

Hit, Lead & Candidate Discovery To discover succinate dehydrogenase inhibitors with a novel structure, we introduced cinnamic acid structure to optimize the lead structure 1 and synthesized four series of cinnamon-pyrazole carboxamide derivatives. The bioassay data showed that compounds (E)-N-(1-[4-chlorophenyl]-4-cyano-1H-pyrazol-5-yl)-3-(2-fluorophenyl) acrylamide (5III-d) and (E)-3-(2-chlorophenyl)-N-(1-[4-chlorophenyl]-4-cyano-1H-pyrazol-5-yl) acrylamide (5III-f) showed the significant antifungal activity against three fungi. In addition, 5III-d and 5III-f exhibited the excellent inhibitory effect against succinate dehydrogenase (SDH) enzymes with IC50 values ranging from 19.4 to 28.7 μM. The study demonstrates that the chlorine substituent group is present on both the phenyl and pyrazole rings that have a very good effect on the antifungal effect, and the compounds 5III-d and 5III-f can act as potential SDH inhibitors (SDHI) and throw a sprat for a new generation of SDHI.

Keywords: 3D-QSAR; cinnamamide; fungicidal activity; molecular docking; pyrazole; succinate dehydrogenase inhibitors.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Antifungal Agents
  • Carboxin / analogs & derivatives*
  • Carboxin / chemistry
  • Carboxin / pharmacology
  • Cinnamates
  • Colletotrichum / drug effects
  • Drug Design
  • Molecular Docking Simulation
  • Plant Diseases / therapy*
  • Quantitative Structure-Activity Relationship
  • Rhizoctonia / drug effects

Substances

  • Antifungal Agents
  • Cinnamates
  • cinnamic acid
  • Carboxin